NIH #P50CA196510
Project 3: Combination inhibition of ERK for pancreatic cancer treatment
- Amount
- $300K–$400K
- Period
- 2016-07-28 → 2021-06-30
- PIs
- 1
Awarded at WASHINGTON UNIVERSITY
Andrea Wang‐Gillam
Full Professor(heuristic)
Pancreatic and Hepatic Oncology Research · Oncology
Compare more Oncology professors.
h-index49
i10-index128
Publications431
Citations15,645
Grants
3 total · 0 active
NIH #UM1CA186704
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
- Amount
- $1M–$2M
- Period
- 2014-04-04 → 2020-02-29
- PIs
- 3
Awarded at DUKE UNIVERSITY
NIH #U54CA224083
Research Project 2: Development of Synergetic EKR Combinations in PDAC
- Amount
- $400K–$500K
- Period
- 2017-09-30 → 2019-08-31
- PIs
- 1
Awarded at WASHINGTON UNIVERSITY
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials (The Lancet. Gastroenterology & hepatology)2025-12-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-14
Data may not be current
Find elsewhere
ORCID: 0000-0003-0458-7614